Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic cancer stroma: controversies and current insights
Daniel Ansari, Maria Carvajo, Monika Bauden, et al.
Scandinavian Journal of Gastroenterology (2017) Vol. 52, Iss. 6-7, pp. 641-646
Closed Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Liquid biopsy approach to pancreatic cancer
Sonia Perales, Carolina Torres, Cristina Jiménez‐Luna, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1263-1287
Open Access | Times Cited: 11
The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer
Raquel Bodoque-Villar, David Padilla, Lucía María González-López, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer
Rubin Jiao, Kevin J. Allen, Mackenzie E. Malo, et al.
Cancer Medicine (2019) Vol. 8, Iss. 11, pp. 5289-5300
Open Access | Times Cited: 10
Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma
David B. Zhen, Andrew L. Coveler, Silvia Zanon, et al.
Seminars in Oncology (2018) Vol. 45, Iss. 3, pp. 107-115
Closed Access | Times Cited: 9
Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer
Sayumi Yoshida, Zensho Ito, Machi Suka, et al.
Cancer Investigation (2019) Vol. 37, Iss. 9, pp. 463-477
Closed Access | Times Cited: 8
Targeting TAM to Tame Pancreatic Cancer
Mitchell S. von Itzstein, Michael Burke, Rolf A. Brekken, et al.
Targeted Oncology (2020) Vol. 15, Iss. 5, pp. 579-588
Open Access | Times Cited: 7
Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients
Konstantin Schlick, Dominik Kiem, Florian Huemer, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 7
Pegvorhyaluronidase alfa
Daniel C. Maneval, Chris L. Caster, Celine Derunes, et al.
Elsevier eBooks (2019), pp. 175-204
Closed Access | Times Cited: 6
Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
Nicole Lintern, Andrew M. Smith, David Jayne, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4135-4135
Open Access | Times Cited: 2
The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data
Dong Yu, Tengjiao Wang, Dong Liang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Digitoxin has specific properties for potential use to treat cancer and inflammatory diseases
Johan Haux
Research and Reviews on Healthcare Open Access Journal (2018) Vol. 2, Iss. 3
Open Access | Times Cited: 4
PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Nicoletta Gagliano, Michele Sommariva
Pancreas - Open Journal (2018) Vol. 2, Iss. 1, pp. e5-e7
Open Access | Times Cited: 1
The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer
Raquel Bodoque-Villar, David Padilla, Lucía María González-López, et al.
Research Square (Research Square) (2023)
Open Access
Species-Deconvolved Proteomics for In Situ Investigation of Tumor-Stroma Interactions after Treatment of Pancreatic Cancer Patient-Derived Xenografts with Combined Gemcitabine and Paclitaxel
Xue Wang, Jin Niu, Shuo Qian, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 7, pp. 2436-2449
Open Access
Evaluation of Tumor Fibrosis in Pancreatic Ductal Adenocarcinoma by 2-D Shear Wave Elastography: A Pilot Study
Kunlong Duan, Huihui Zhou, Wanni Xu, et al.
Ultrasound in Medicine & Biology (2023) Vol. 49, Iss. 9, pp. 2119-2125
Open Access
Response to re: Metabolomic prostate cancer fields in HRMAS MRS‐profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al., NBM 2019
Leo K. Cheng
NMR in Biomedicine (2019) Vol. 32, Iss. 8
Closed Access
Pancreatic Cancer; Biomolecular and Genetic Aspects
Jin Woo Yoo, James J. Farrell
Elsevier eBooks (2019), pp. 30-38
Closed Access
Previous Page - Page 2

Scroll to top